IL-13-induced changes in the goblet cell density of human bronchial epithelial cell cultures: MAP kinase and phosphatidylinositol 3-kinase regulation

American Journal of Physiology - Lung Cellular and Molecular Physiology

Volumn 285, Issue 3 29-3, 2003, Pages

  Atherton, Hazel C ^a   Jones, Gareth ^a   Danahay, Henry ^a  

^a Novartis Institutes for Biomedical Research   (United Kingdom)

Author keywords

Cytokine; Hypersecretion; Inflammation; MUC5AC

Indexed keywords

1,4 DIAMINO 1,4 BIS(2 AMINOPHENYLTHIO) 2,3 DICYANOBUTADIENE; 2 (2 AMINO 3 METHOXYPHENYL)CHROMONE; 2 MORPHOLINO 8 PHENYLCHROMONE; 4 (3 CHLOROANILINO) 6,7 DIMETHOXYQUINAZOLINE; 4 (4 FLUOROPHENYL) 2 (4 HYDROXYPHENYL) 5 (4 PYRIDYL)IMIDAZOLE; ALCIAN BLUE; EPIDERMAL GROWTH FACTOR RECEPTOR KINASE; INTERLEUKIN 13; INTERLEUKIN 4; MITOGEN ACTIVATED PROTEIN KINASE; MUCIN; MUCIN 5AC; PHOSPHATIDYLINOSITOL 3 KINASE; UNCLASSIFIED DRUG;

ARTICLE; BRONCHUS MUCOSA; CELL CULTURE; CELL DENSITY; CONCENTRATION RESPONSE; CONTROLLED STUDY; GOBLET CELL; HUMAN; HUMAN CELL; IMMUNOHISTOCHEMISTRY; INFLAMMATION; ION TRANSPORT; MUCUS SECRETION; PHENOTYPE; PRIORITY JOURNAL;

EID: 0043011579     PISSN: 10400605     EISSN: None     Source Type: Journal    
DOI: 10.1152/ajplung.00089.2003     Document Type: Article

References (44)

1. Akaiwa M, Yu B, Umeshita-Suyama R, Terada N, Suto H, Koga T, Arima K, Matsushita S, Saito H, Ogawa H, Furue M, Hamasaki N, Ohshima K, and Izuhara K. Localization of human interleukin 13 receptor in non-haematopoietic cells. Cytokine 13: 75-84, 2001.
2. Booth BW, Adler KB, Bonner JC, Tournier F, and Martin LD. Interleukin-13 induces proliferation of human airway epithelial cells in vitro via a mechanism mediated by transforming growth factor-alpha. Am J Respir Cell Mol Biol 25: 739-743, 2001.
3. Boucher RC. Human airway ion transport. Part one. Am J Respir Crit Care Med 150: 271-281, 1994.
4. Brown CD, Kilty I, Yeadon M, and Jenkinson S. Regulation of 15-lipoxygenase isozymes and mucin secretion by cytokines in cultured normal human bronchial epithelial cells. Inflamm Res 50: 321-326, 2001.
5. Chang CI, Zoghi B, Liao JC, and Kuo L. The involvement of tyrosine kinases, cyclic AMP/protein kinase A, and p38 mitogen-activated protein kinase in IL-13-mediated arginase I induction in macrophages: its implications in IL-13-inhibited nitric oxide production. J Immunol 165: 2134-2141, 2000.
6. Chen Y, Thai P, Zhao YH, Ho YS, DeSouza MM, and Wu R. Stimulation of airway mucin gene expression by interleukin (IL)-17 through IL-6 paracrine/autocrine loop. J Biol Chem 278: 17036-17043, 2003.
7. Coles SJ, Levine LR, and Reid L. Hypersecretion of mucus glycoproteins in rat airways induced by tobacco smoke. Am J Pathol 94: 459-471, 1979.
8. Corry DB and Kheradmand F. Biology and therapeutic potential of the interleukin-4/interleukin-13 signaling pathway in asthma. Am J Respir Med 1: 185, 2002,
9. Danahay H, Atherton H, Jones G, Bridges RJ, and Poll CT. Interleukin-13 induces a hypersecretory ion transport phenotype in human bronchial epithelial cells. Am J Physiol Lung Cell Mol Physiol 282: L226-L236, 2002.
10. David M, Ford D, Bertoglio J, Maizel AL, and Pierre J. Induction of the IL-13 receptor alpha2-chain by IL-4 and IL-13 in human keratinocytes: involvement of STAT6, ERK and p38 MAPK pathways. Oncogene 20: 6660-6668, 2001.
11. Galietta LJ, Pagesy P, Folli C, Caci E, Romio L, Costes B, Nicolis E, Cabrini G, Goossens M, Ravazzolo R, and Zegarra-Moran O. IL-4 is a potent modulator of ion transport in the human bronchial epithelium in vitro. J Immunol 168: 839-845, 2002.
12. Gavett SH, O'Hearn DJ, Karp CL, Patel EA, Schofield BH, Finkelman FD, and Wills-Karp M. Interleukin-4 receptor blockade prevents airway responses induced by antigen challenge in mice. Am J Physiol Lung Cell Mol Physiol 272: L253-L261, 1997.
13. Gray TE, Guzman K, Davis CW, Abdullah LH, and Nettesheim P. Mucociliary differentiation of serially passaged normal human tracheobronchial epithelial cells. Am J Respir Cell Mol Biol 14: 104-112, 1996.
14. Grunig G, Warnock M, Wakil AE, Venkayya R, Brombacher F, Rennick DM, Sheppard D, Mohrs M, Donaldson DD, Locksley RM, and Corry DB. Requirement for IL-13 independently of IL-4 in experimental asthma. Science 282: 2261-2263, 1998.
15. Hirst SJ, Hallsworth MP, Peng Q, and Lee TH. Selective induction of eotaxin release by interleukin-13 or interleukin-4 in human airway smooth muscle cells is synergistic with interleukin-1beta and is mediated by the interleukin-4 receptor alpha-chain. Am J Respir Crit Care Med 165: 1161-1171, 2002.
16. Holgate ST, Lackie P, Wilson S, Roche W, and Davies D. Bronchial epithelium as a key regulator of airway allergen sensitisation and remodelling in asthma. Am J Respir Crit Care Med 162: S113-S117, 2000.
17. Jayawiekreme SP, Gray T, Nettesheim P, and Eling T. Regulation of 15-lipoxygenase expression and mucus secretion by IL-4 in human bronchial epithelial cells. Am J Physiol Lung Cell Mol Physiol 276: L596-L603, 1999.
18. Jiang H, Harris MB, and Rothman P. IL-4/IL-13 signaling beyond JAK/STAT. J Allergy Clin Immunol 105: 1063-1070, 2000.
19. Kim CH, Song KS, Koo JS, Kim HU, Cho JY, Kim HJ, and Yoon YH. IL-13 suppresses MUC5AC gene expression and mucin secretion in nasal epithelial cells. Acta Otolaryngol (Stockh) 22: 638-643, 2002.
20. Kim YD, Jeon JY, Woo HJ, Lee JC, Chung JH, Song SY, Yoon SK, and Baek SH. Interleukin-1β induces MUC2 gene expression and mucin secretion via activation of PKC-MEK/ ERK, and PI3K in human airway epithelial cells. J Korean Med Sci 17: 765-771, 2002.
21. Knowles MR and Boucher RC. Mucus clearance as a primary innate defense mechanism for mammalian airways. J Clin Invest 109: 571-577, 2002.
22. Kondo M, Tamaoki J, Takeyama K, Nakata J, and Nagai A. Interleukin-13 induces goblet cell differentiation in primary cell culture from guinea pig tracheal epithelium. Am J Respir Cell Mol Biol 27: 536-541, 2002.
23. Kuperman D, Schofield B, Wills-Karp M, and Grusby MJ. Signal transducer and activator of transcription factor 6 (Stat6)-deficient mice are protected from antigen-induced airway hyperresponsiveness and mucus production. J Exp Med 187: 939-948, 1998.
24. Kuperman DA, Huang X, Koth LL, Chang GH, Dolganov GM, Zhu Z, Elias JA, Sheppard D, and Erle DJ. Direct effects of interleukin-13 on epithelial cells cause airway hyperreactivity and mucus overproduction in asthma. Nat Med 8: 885-889, 2002.
25. Laoukili J, Perret E, Willems T, Minty A, Parthoens E, Houcine O, Coste A, Jorissen M, Marano F, Caput D, and Tournier F. IL-13 alters mucociliary differentiation and ciliary beating of human respiratory epithelial cells. J Clin Invest 108: 817-824, 2001.
26. Laporte JC, Moore PE, Baraldo S, Jouvin MH, Church TL, Schwartzman IN, Panettieri RA Jr, Kinet JP, and Shore SA. Direct effects of interleukin-13 on signaling pathways for physiological responses in cultured human airway smooth muscle cells. Am J Respir Crit Care Med 164: 141-148, 2001.
27. Lee HW, Ahn DH, Crawley SC, Li JD, Gum JR Jr, Basbaum CB, Fan NQ, Szymkowski DE, Han SY, Lee BH, Sleisenger MH, and Kim YS. Phorbol 12-myristate 13-acetate up-regulates the transcription of MUC2 intestinal mucin via Ras, ERK, and NF-kappa B. J Biol Chem 277: 32624-32631, 2002.
28. Li JD, Feng W, Gallup M, Kim JH, Gum J, Kim Y, and Basbaum C. Activation of NF-kappaB via a Src-dependent Ras-MAPK-pp90rsk pathway is required for Pseudomonas aeruginosa-induced mucin overproduction in epithelial cells. Proc Natl Acad Sci USA 95: 5718-5723, 1998.
29. Li W, Chen Q, Mills I, and Sumpio BE. Involvement of S6 kinase and p38 mitogen activated protein kinase pathways in strain-induced alignment and proliferation of bovine aortic smooth muscle cells. J Cell Physiol 195: 202-209, 2003.
30. Locher R, Brandes RP, Vetter W, and Barton M. Native LDL induces proliferation of human vascular smooth muscle cells via redox-mediated activation of ERK 1/2 mitogen-activated protein kinases. Hypertension 39: 645-650, 2002.
31. Martin LD, Rochelle LG, Fischer BM, Krunkosy TM, and Adler KB. Airway epithelium as an effector of inflammation: molecular regulation of secondary mediators. Eur Respir J 10: 2139-2146, 1997.
32. Masamune A, Satoh M, Kikuta K, Sakai Y, Satoh A, and Shimosegawa T. Inhibition of p38 mitogen-activated protein kinase blocks activation of rat pancreatic stellate cells. J Pharmacol Exp Ther 304: 8-14, 2003.
33. Moore PE, Church TL, Chism DD, Panettieri RA Jr, and Shore SA. IL-13 and IL-4 cause eotaxin release in human airway smooth muscle cells: a role for ERK. Am J Physiol Lung Cell Mol Physiol 282: L847-L853, 2002.
34. Murata T, Obiri NI, and Puri RK. Structure of and signal transduction through interleukin-4 and interleukin-13 receptors. Int J Mol Med 1: 551-557, 1998.
35. Nadel JA. Role of epidermal growth factor receptor activation in regulating mucin synthesis. Respir Res 2: 85-89, 2001.
36. Puddicombe SM, Polosa R, Richter A, Krishna MT, Howarth PH, Holgate ST, and Davies DE. Involvement of the epidermal growth factor receptor in epithelial repair in asthma. FASEB J 14: 1362-1374, 2000.
37. Shim JJ, Dabbagh K, Ueki IF, Dao-Pick T, Burgel PR, Takeyama K, Tam DC, and Nadel JA. IL-13 induces mucin production by stimulating epidermal growth factor receptors and by activating neutrophils. Am J Physiol Lung Cell Mol Physiol 280: L134-L140, 2001.
38. Shimizu T, Takahashi Y, Kawaguchi S, and Sakakura Y. Hypertrophic and metaplastic changes of goblet cells in rat nasal epithelium induced by endotoxin. Am J Respir Crit Care Med 153: 1412-1418, 1996.
39. Takeyama K, Dabbagh K, Lee HM, Agusti C, Lausier JA, Ueki IF, Grattan KM, and Nadel JA. Epidermal growth factor system regulates mucin production in airways. Proc Natl Acad Sci USA 96: 3081-3086, 1999.
40. Verdugo P. Mucin exocytosis. Am Rev Respir Dis 144: S33-S37, 1991.
41. Vermeer PD, Harson R, Einwalter LA, Moninger T, and Zabner J. Interleukin-9 induces goblet cell hyperplasia during repair of human airway epithelia. Am J Respir Cell Mol Biol 28: 286-295, 2003.
42. Wang B, Lim DJ, Han J, Kim YS, Basbaum CB, and Li JD. Novel cytoplasmic proteins of nontypeable Haemophilus influenzae up-regulate human MUC5AC mucin transcription via a positive p38 mitogen-activated protein kinase pathway and a negative phosphoinositide 3-kinase-Akt pathway. J Biol Chem 277: 949-957, 2002.
43. Wills-Karp M, Luyimbazi J, Xu X, Schofield B, Neben TY, Karp CL, and Donaldson DD. Interleukin-13: central mediator of allergic asthma. Science 282: 2258-2261, 1998.
44. Zhu Z, Homer RJ, Wang Z, Chen Q, Geba GP, Wang J, Zhang Y, and Elias JA. Pulmonary expression of interleukin-13 causes inflammation, mucus hypersecretion, subepithelial fibrosis, physiologic abnormalities, and eotaxin production. J Clin Invest 103: 779-788, 1999.